Recognize the burden of pediatric atopic dermatitis and the effects of type 2 inflammation on skin barrier function - a short expert interview.
EPI-CARE and PEDISTAD are two studies assessing the prevalence and burden of atopic dermatitis. In this expert interview, Dr. Antonella Muraro, MD (Centro Allergie Alimentari, Italy) showcases PEDISTAD and EPI-CARE data, highlighting the burden of atopic dermatitis in children. She also recognizes the effects of type 2 inflammation on skin barrier structure and function.
Consultant Pediatric Allergist at the Department of Pediatrics of the University of Padova, Italy
See author’s profile